1. It’s going up on analyst upgrades and BARDA news imo currently.
2. Recell basically has a monopoly at present. There’s competition, but Recell is the best bang for the buck imo.
3. There’s a plethora of studies that back up Recell’s safety and effectiveness profile. But there are no guarantees that issues won’t arise in the future. Recell’s simplicity is its core strength imo. Spraying a patient’s own skin back on is much safer than lab-grown products. Other products seem to have more adverse events.
Hope this helps.
AVH Chart, page-655
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.17 |
Change
0.180(6.02%) |
Mkt cap ! $223.2M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.18 | $3.12 | $1.124M | 356.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 410 | $3.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.17 | 2434 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |